Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier

Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2017
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (183 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993543792804498
ctrlnum (CKB)4100000002484751
(oapen)https://directory.doabooks.org/handle/20.500.12854/61823
(EXLCZ)994100000002484751
collection bib_alma
record_format marc
spelling Carlos P. Taborda auth
Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi
Vaccines; Immunotherapy and New Antifungal Therapy Against Fungi
Frontiers Media SA 2017
1 electronic resource (183 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi.
English
antifugal drugs
vaccine
peptide
antibody
virulence
fungi
immunotherapy
humanized antibody
mycosis
cell biology
2-88945-327-8
Joshua D. Nosanchuk auth
language English
format eBook
author Carlos P. Taborda
spellingShingle Carlos P. Taborda
Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
Frontiers Research Topics
author_facet Carlos P. Taborda
Joshua D. Nosanchuk
author_variant c p t cpt
author2 Joshua D. Nosanchuk
author2_variant j d n jdn
author_sort Carlos P. Taborda
title Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_full Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_fullStr Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_full_unstemmed Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_auth Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_alt Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi
Vaccines; Immunotherapy and New Antifungal Therapy Against Fungi
title_new Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
title_sort vaccines, immunotherapy and new antifungal therapy against fungi: updates in the new frontier
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2017
physical 1 electronic resource (183 p.)
isbn 2-88945-327-8
illustrated Not Illustrated
work_keys_str_mv AT carlosptaborda vaccinesimmunotherapyandnewantifungaltherapyagainstfungiupdatesinthenewfrontier
AT joshuadnosanchuk vaccinesimmunotherapyandnewantifungaltherapyagainstfungiupdatesinthenewfrontier
AT carlosptaborda vaccinesimmunotherapyandnewantifungaltherapyagainstfungi
AT joshuadnosanchuk vaccinesimmunotherapyandnewantifungaltherapyagainstfungi
status_str n
ids_txt_mv (CKB)4100000002484751
(oapen)https://directory.doabooks.org/handle/20.500.12854/61823
(EXLCZ)994100000002484751
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
container_title Frontiers Research Topics
author2_original_writing_str_mv noLinkedField
_version_ 1787548770184986624
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02213nam-a2200421z--4500</leader><controlfield tag="001">993543792804498</controlfield><controlfield tag="005">20231214133246.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2017 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000002484751</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61823</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000002484751</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carlos P. Taborda</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Vaccines; Immunotherapy and New Antifungal Therapy Against Fungi</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (183 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antifugal drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibody</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virulence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fungi</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">humanized antibody</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mycosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell biology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-327-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joshua D. Nosanchuk</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-03-10 17:16:05 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337400400004498&amp;Force_direct=true</subfield><subfield code="Z">5337400400004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337400400004498</subfield></datafield></record></collection>